Clonidine prevents insulin resistance and hypertension in obese dogs

Hypertension

Volumn 33, Issue 1 II, 1999, Pages 548-553

  Rocchini, Albert P ^a,d   Mao, Hui Z ^c   Babu, Keshava ^c   Marker, Paul ^b   Rocchini, Albert J ^c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Cardiac output; Clonidine; Hypertension, arterial; Insulin resistance; Obesity; Sympathetic nervous system

Indexed keywords

CLONIDINE;

ANIMAL EXPERIMENT; ARTICLE; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; FEMALE; HEART OUTPUT; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL;

EID: 0032947371     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.33.1.548     Document Type: Article

References (29)

1. Rocchini AP, Marker P, Cervenka T. Time course of insulin resistance associated with feeding dogs a high-fat diet. Am J Physiol. 1997;272: E147-E154.
2. Rocchini AP, Moorehead CS, DeRemer S, Bondie D. Pathogenesis of weight-related changes in pressure in the dog. Hypertension. 1989;13: 922-928.
3. O'Hare JA. The enigma of insulin resistance and hypertension, insulin resistance, blood pressure and the circulation. Am J Med. 1988;84: 505-510.
4. Ferrannini E, Haffner SM, Stern MP. Essential hypertension: an insulin-resistance state. J Cardiovasc Pharmacol. 1990;15(suppl 5):S18-S25.
5. Hall JE, Brands MW, Kivlighn SD, Mizelle HL, Hidebrandt DA, Gaillard CA. Chronic hyperinsulinemia and blood pressure: interaction with catecholamines? Hypertension. 1990;15:519-527.
6. Sowers JR, Nyby M, Stern N, Beck F, Baron S, Catania R, Vlachis N. Blood pressure and hormonal changes associated with weight reduction in the obese. Hypertension. 1982;4:686-691.
7. Hall JE, Van Vliet BN, Garrity CA, Connell RD, Brands MW. Role of increased adrenergic activity in obesity-induced hypertension. Circulation. 1992;86(suppl I):I-541. Abstract.
8. Young JB, Saville ME, Rothwell NJ, Stock MJ, Landsberg L. Effect of diet and cold exposure on norepinephrine turnover in brown adipose tissue in the rat. J Clin Invest. 1982;69:1061-1071.
9. Diebert DC, DeFronzo RA. Epinephrine-induced insulin resistance in man. J Clin Invest. 1980;65:717-721.
10. Jamerson KA, Julius A, Gudbrandsson T, Andersson O, Brant DO. Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension. 1993;21:618-623.
11. Finegood DT, Bergman RN, Vranic M. Estimation of endogenous glucose production during hyperinsulinemic euglycemic glucose clamps: comparison of unlabeled and labeled exogenous glucose infusates. Diabetes. 1987;36:914-924.
12. DeLean A, Munson PJ, Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay and physiological dose-response curves. Am J Physiol. 1978;235:E97-E102.
13. Van Zwieten PA. Centrally acting antihypertensives: a renaissance of interest. Mechanisms and haemodynamics. J Hypertens. 1997;15:S3-S8.
14. Kassab S, Kato T, Wilkins FC, Chen R, Hall JE, Granger JP. Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension. 1995:25:893-897.
15. Julius S, Gudbrandsson T, Jamerson K, Shahab ST, Andersson O. The hemodynamic link between insulin resistance and hypertension. J Hypertens. 1991;9:983-986.
16. Giugliano D, Acampora R, Marfella R, La Marca C, Marfella M, Nappo F, D'Onofrio F. Hemodynamic and metabolic effects of transdermal clonidine in patients with hypertension and non-insulin-dependent diabetes mellitus. Am J Hypertens 1998;11:184-189.
17. Rosen P, Ohly P, Gleochman J. Experimental benefit of moxonidine on glucose metabolism and insulin secretion in the fructose-fed rat. J Hypertens. 1997;15(suppl I):S31-S38.
18. Ernsberger P, Friedman JE, Kooletsky RJ. The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease. J Hypertens. 1997;15(suppl I):S9-S23.
19. Hwang I, Ho H, Hoffman B, Reaven G. Fructose-induced insulin resistance and hypertension in rats. Hypertension. 1987;10:512-516.
20. Metz SA, Halter JB, Robertson RP. Induction of defective insulin secretion and impaired glucose tolerance by clonidine. Diabetes. 1978;27:554-562.
21. Barbieri C, Caldara R, Testori G, Pierpoli V, Trezzi R, Romussi M, Ferrari C. Oral glucose tolerance and insulin response after one week's clonidine treatment in hypertensive patients. Acta Diabetol Lantina. 1981;18:59-63.
22. Baron AD, Laakso M, Brechtel G, Edelman SV. Mechanism of insulin resistance in insulin-dependent diabetes mellitus: a major role for reduced skeletal muscle blood flow. J Clin Endocrinol Metab. 1991;73:637-643.
23. Vollenweider P, Randin B, Tappy L, Jequier E, Nicod P, Scherrer U. Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. J Clin Invest. 1994;93:2365-2371.
24. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent: a novel action of insulin to increase nitric oxide release. J Clin Invest. 1994;94:1172-1179.
25. 2- and beta-adrenergic responses in human forearm. J Clin Invest. 1997;100:2007-2014.
26. Lacolley PJ, Lewis SJ, Brody MJ. Role of sympathetic nerve activity in the generation of vascular nitric oxide in urethane-anesthetized rats. Hypertension. 1991;17:881-887.
27. Takahashi A, Sudo M, Minokoshi Y, Shimazua T. Effect of ventromedial hypothalamic stimulation on glucose transport system in rat tissue. Am J Physiol. 1992;263:R1228-R1234.
28. Haring HU, Kirsch D, Obermaier B, Ermel B, Machicaco F. Reduced tyrosine kinase activity of insulin receptor isolated from rat adipocytes rendered insulin resistant by catecholamine treatment in vitro. Biochem J. 1986;234:59-66.
29. Swislocki ALM, Vestal RE, Reaven GM, Hoffman BB. Acute metabolic effects of clonidine and adenosine in man. Horm Metab Res. 1993;25:90-95.